SKIN financial statements and SEC filings
SKIN annual income statement
| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
|---|
| 2025-12-31 | $300.79M | -$20.80M | -$9.52M | 10-K |
| 2024-12-31 | $334.29M | -$67.77M | -$29.10M | 10-K |
| 2023-12-31 | $397.99M | -$130.92M | -$100.12M | 10-K |
| 2022-12-31 | $365.88M | -$25.84M | $44.22M | 10-K |
| 2021-12-31 | $260.09M | -$39.93M | -$378.76M | 10-K |
| 2020-12-31 | $119.09M | -$17.18M | -$29.18M | 10-K |
SKIN annual balance sheet
| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
|---|
| 2025-12-31 | $499.80M | $438.75M | $61.06M | 10-Q |
| 2024-12-31 | $685.68M | $633.88M | $51.80M | 10-K |
| 2023-12-31 | $929.11M | $869.72M | $59.39M | 10-K |
| 2022-12-31 | $1.00B | $836.03M | $167.05M | 10-K |
| 2021-12-31 | $1.22B | $916.51M | $302.30M | 10-K |
| 2020-12-31 | $222.84M | $252.79M | -$29.96M | 10-K |
SKIN annual cash flow
| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
|---|
| 2025-12-31 | $37.48M | -$303.00K | -$174.93M | 10-K |
| 2024-12-31 | $16.13M | -$756.00K | -$158.34M | 10-K |
| 2023-12-31 | $21.75M | -$3.83M | -$37.45M | 10-K |
| 2022-12-31 | -$106.60M | -$10.85M | -$205.24M | 10-K |
| 2021-12-31 | -$28.36M | -$11.20M | $959.03M | 10-K |
| 2020-12-31 | -$12.44M | -$3.50M | $18.27M | 10-K |